Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …

Use of prescription stimulants by normal healthy individuals to enhance cognition is said to
be on the rise. Who is using these medications for cognitive enhancement, and how …

Neurophysiological experiments in primates, alongside neuropsychological and functional
magnetic resonance investigations in humans, have significantly enhanced our …

Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

A growing trend of neuroimaging, behavioral, and computational research has investigated
the topic of outcome uncertainty in decision-making. Although evidence to date indicates …

Methylphenidate (MPH) is a stimulant drug that amplifies dopamineric and noradrenergic
signaling in the brain, which is believed to underlie its cognition enhancing effects. However …

Uncertainty is often inevitable in everyday life and can be both stressful and exciting. Given
its relevance to psychopathology and wellbeing, recent research has begun to address the …

Introduction Theory of visual attention (TVA; Bundesen 1990) whole report tasks allow the
independent measurement of visual perceptual processing speed and visual short-term …

In patients with schizophrenia, the ability to learn from reinforcement is known to be
impaired. The present fMRI study aimed at investigating the neural correlates of …

Increasing numbers of adults, particularly college students, are misusing prescription
stimulants primarily for cognitive/academic enhancement, so it is critical to explore whether …